Quarterly report [Sections 13 or 15(d)]

Fair Value of Financial Instruments - Narrative (Details)

v3.25.2
Fair Value of Financial Instruments - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Feb. 25, 2025
Dec. 31, 2024
Sep. 30, 2021
Subsidiary, Sale of Stock [Line Items]              
Changes in fair value     $ 2,692        
Common Stock              
Subsidiary, Sale of Stock [Line Items]              
Common issued for warrants exercised (in shares)     9,499,138        
Private Warrants              
Subsidiary, Sale of Stock [Line Items]              
Warrants outstanding (in shares) 2,633,195   2,633,195   5,098,978 7,732,168 7,732,168
Number of warrants to purchase common stock (in shares)             1
Fair value (in dollars per share) $ 8.74   $ 8.74   $ 6.84 $ 7.15  
Changes in fair value $ 16,300 $ 9,000 $ 2,700 $ 10,100      
Proceeds from warrant exercises     $ 5,400        
Class of warrants exercised (in shares)     4,631,799        
Warrants exercised (in shares)     467,174        
Private Warrants | Common Stock              
Subsidiary, Sale of Stock [Line Items]              
Common issued for warrants exercised (in shares)     2,293,739        
Warrants exercised (in shares)     467,174        
Public Warrants              
Subsidiary, Sale of Stock [Line Items]              
Warrants outstanding (in shares) 0   0     8,188,811  
Number of warrants to purchase common stock (in shares) 1   1        
Fair value (in dollars per share) $ 11.50   $ 11.50       $ 11.50
Proceeds from warrant exercises     $ 77,500